doi: 10.1099/0022-1317-69-10-2607.
Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target
Affiliations
- PMID: 2844969
- DOI: 10.1099/0022-1317-69-10-2607
Item in Clipboard
Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target
J Gen Virol.
1988 Oct.
Abstract
The role of the herpes simplex virus (HSV)-encoded ribonucleotide reductase (RR) in the pathogenicity of the virus has been examined by use of mutants with lesions in either the large or small subunit of the enzyme. The virulence of the mutants in mice was reduced by about 10(6)-fold when compared with that of the parental virus (HSV type 1 strain 17), while the virulence of a revertant of one of the mutants was restored to within about 100-fold of that of the parent virus. These experiments demonstrate that activity of the HSV RR is essential for virus pathogenicity in mice and suggests that the enzyme is a valid target for specific antiviral compounds.
Similar articles
-
The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice.J Infect Dis. 1991 Dec;164(6):1091-7. doi: 10.1093/infdis/164.6.1091. J Infect Dis. 1991. PMID: 1659596
-
The herpes simplex virus ribonucleotide reductase is required for ocular virulence.J Gen Virol. 1991 Sep;72 ( Pt 9):2043-9. doi: 10.1099/0022-1317-72-9-2043. J Gen Virol. 1991. PMID: 1654368
-
Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo.Antiviral Res. 1992 Feb;17(2):145-56. doi: 10.1016/0166-3542(92)90048-a. Antiviral Res. 1992. PMID: 1313220
-
Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.Nature. 1986 May 22-28;321(6068):439-41. doi: 10.1038/321439a0. Nature. 1986. PMID: 3012359
-
Identification of a herpes simplex virus type 1 polypeptide which is a component of the virus-induced ribonucleotide reductase.J Gen Virol. 1984 Sep;65 ( Pt 9):1457-66. doi: 10.1099/0022-1317-65-9-1457. J Gen Virol. 1984. PMID: 6088678
Cited by
-
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant.J Virol. 1994 Nov;68(11):7083-91. doi: 10.1128/JVI.68.11.7083-7091.1994. J Virol. 1994. PMID: 7933090 Free PMC article.
-
Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir.Antimicrob Agents Chemother. 1993 May;37(5):975-9. doi: 10.1128/AAC.37.5.975. Antimicrob Agents Chemother. 1993. PMID: 8390815 Free PMC article.
-
Restricting HIV the SAMHD1 way: through nucleotide starvation.Nat Rev Microbiol. 2012 Oct;10(10):675-80. doi: 10.1038/nrmicro2862. Epub 2012 Aug 28. Nat Rev Microbiol. 2012. PMID: 22926205
-
Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency.J Virol. 1992 Nov;66(11):6706-13. doi: 10.1128/JVI.66.11.6706-6713.1992. J Virol. 1992. PMID: 1328686 Free PMC article.
-
Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates.J Virol. 1996 Feb;70(2):787-93. doi: 10.1128/JVI.70.2.787-793.1996. J Virol. 1996. PMID: 8551616 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
